denosumab-bbdz

denosumab-bbdz (JUBBONTI) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.

JUBBONTI is a marketed brand name for denosumab-bbdz. Check FDA Drugs@FDA for the current US label holder and prescribing information.

denosumab-bbdz has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.